Tema Heart & Health ETF (NASDAQ:HRTS) Trading Up 0.2% – Time to Buy?

Tema Heart & Health ETF (NASDAQ:HRTS) was up 0.2% on Thursday . The stock traded as high as $36.95 and last traded at $36.80. Approximately 3,298 shares traded hands during mid-day trading, a decline of 48% from the average daily volume of 6,325 shares. The stock had previously closed at $36.72.

Tema Heart & Health ETF Stock Performance

The stock has a market cap of $55.52 million, a price-to-earnings ratio of 22.06 and a beta of 0.63. The stock has a fifty day simple moving average of $35.71 and a two-hundred day simple moving average of $34.92.

Hedge Funds Weigh In On Tema Heart & Health ETF

Several large investors have recently modified their holdings of the business. Citadel Advisors LLC acquired a new position in shares of Tema Heart & Health ETF in the 3rd quarter valued at about $243,000. Stifel Financial Corp increased its holdings in Tema Heart & Health ETF by 19.8% in the fourth quarter. Stifel Financial Corp now owns 33,647 shares of the company’s stock worth $1,187,000 after purchasing an additional 5,571 shares in the last quarter. Jane Street Group LLC increased its holdings in Tema Heart & Health ETF by 9.4% in the second quarter. Jane Street Group LLC now owns 37,164 shares of the company’s stock worth $1,062,000 after purchasing an additional 3,202 shares in the last quarter. JPMorgan Chase & Co. acquired a new position in Tema Heart & Health ETF in the second quarter valued at approximately $63,000. Finally, Royal Bank of Canada boosted its holdings in shares of Tema Heart & Health ETF by 8.8% during the 1st quarter. Royal Bank of Canada now owns 21,083 shares of the company’s stock worth $710,000 after buying an additional 1,703 shares in the last quarter.

About Tema Heart & Health ETF

The Tema Obesity & Cardiometabolic ETF (HRTS) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that concentrates on companies focused on the treatment of cardiovascular diseases and/or metabolic diseases from companies all around the world. Using both top-down and bottom-up stock selection, the fund identifies innovative companies deemed attractive. HRTS was launched on Nov 20, 2023 and is issued by Tema.